Human lipopolysaccharides antibody IgG (LPS-IgG) ELISA Kit (Quantitative) |
SL3130Hu_1 |
Sunlong |
96 Tests |
EUR 468 |
|
Human IgG antibody Laboratories manufactures the elisa quantitative for protein concentration reagents distributed by Genprice. The Elisa Quantitative For Protein Concentration reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact protein elisa. Other Elisa products are available in stock. Specificity: Elisa Category: Quantitative Group: For Protein
88 Allergen IgG Screening ELISA Kit for Human (1 patient), Quantitative |
Alpha Diagnostics |
1 Kit |
EUR 927.6 |
Human Mumps IgG ELISA Kit (quantitative) |
Sunlong |
96 Tests |
EUR 468 |
|
Human Anti-Aflibercept/Eylea IgG (anti-drug IgG) ELISA Kit for human, 96 tests, quantitative |
Alpha Diagnostics |
1 Kit |
EUR 1365.6 |
Human Anti-Avastin/Bevacizumab IgG (anti-drug IgG) ELISA Kit for human, 96 tests, quantitative |
Alpha Diagnostics |
1 kit |
EUR 1365.6 |
Human Anti-Lucentis/Ranibizumab IgG (anti-drug IgG) ELISA Kit for human, 96 tests, quantitative |
Alpha Diagnostics |
1 Kit |
EUR 1365.6 |
Human herpesvirus 6 antibody IgG (HHV6- IgG) ELISA Kit (Quantitative) |
Sunlong |
96 Tests |
EUR 468 |
|
Human anti-Endomysial Antibody IgG,EMA IgG ELISA Kit(Quantitative) |
Sunlong |
96 Tests |
EUR 468 |
|
For Protein information
ProteoSpin™ Urine Protein Concentration Midi Kit |
52300 |
Norgen Biotek Corp |
10 Preps |
EUR 171 |
ProteoSpin™ Urine Protein Concentration Maxi Kit |
21600 |
Norgen Biotek Corp |
4 Preps |
EUR 89.4 |
Cas9 Nuclease GFP NLS Protein (High Concentration) |
K148 |
ABM |
47µg (250pmol) Volume: 25µL |
EUR 155 |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR). ;The Cas9 from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. ;The fusion of Cas9 Nuclease NLS to GFP allows for visual confirmation of transfection as well as subsequent verification of Cas9 clearance from the cells. Cas9 Nuclease-GFP can also be used for FACS applications and screening. Cas9 Nuclease-GFP NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. Our Cas9-GFP proteins have the Enhanced green fluorescent protein (eGFP). |
Cas9 Nickase D10A NLS Protein (High Concentration) |
K134 |
ABM |
40 µg (250pmol) Volume: 25µL |
EUR 135 |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. One concern with the current CRISPR Cas9 technology is the potential off-target effects of the Cas9 nuclease. ;;To counteract off-target mutagenic effects of this system, the Cas9 Nickase D10A was developed with a D10A mutation in its RuvC1 nuclease domain. Unlike the Cas9 nuclease, this mutant form generates a single-stranded nick instead of a double-strand break (DSB). Because a single DNA nick is quickly repaired with high fidelity by the cellular machinery, the system requires two closely juxtaposed nicks in order to trigger the same genomic disruption as the Cas9 nuclease. This effectively boosts the recognition sequence to 40 instead of 20 nucleotides, and, as a result, off-target effects become highly unlikely. Thus, the double-nickase CRISPR system offers unparalleled specificity to satisfy even the most stringent of experimental requirements.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First, the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 D10A Nickase NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. |
Cumate Solution, high concentration, 10,000x for use with PiggyBac |
PBQM100A-1 |
SBI |
500 ul |
EUR 106 |
Gas concentration agent |
nBIONIX-A07 |
Bulldog Bio |
20 |
EUR 138 |
Cas9 Nickase H840A NLS Protein (High Concentration) |
K138 |
ABM |
40 µg (250pmol) Volume: 25µL |
EUR 135 |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. One concern with the current CRISPR Cas9 technology is the potential off-target effects of the Cas9 nuclease. ;;To improve the off-target mutagenic effects of this system, the Cas9 Nickase H840A Protein was developed with a H840A mutation in its HNH-like nuclease domain. Unlike the Cas9 nuclease, this mutant form generates a single-stranded nick instead of a double-strand break (DSB). Because a single DNA nick is quickly repaired with high fidelity by the cellular machinery, the system requires two closely juxtaposed nicks in order to trigger the same genomic disruption as the Cas9 nuclease. This effectively boosts the recognition sequence to 40 instead of 20 nucleotides, and, as a result, off-target effects become highly unlikely. Thus, the double-nickase CRISPR system offers unparalleled specificity to satisfy even the most stringent of experimental requirements.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First, the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 H840 Nickase NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First, the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 H840 Nickase NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. |
saCas9 Null Mutant NLS Protein (High Concentration) |
K147 |
ABM |
32.5 µg (250pmol) Volume: 25µL |
EUR 155 |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The saCas9 Null Mutant Protein is created by mutating both cleavage domains of the wild type saCas9. Such a saCas9 protein retains its ability to bind to genomic DNA through gRNA:genomic DNA base pairing, however, the saCas9 Null Mutant does not introduce any genome modifications. Therefore, this protein can provide a useful negative control for CRISPR experiments. In addition, binding of the Null Mutant can act as a roadblock to hinder transcription, thus offering a useful tool to achieve reversible knock-down of gene expression.;; The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). saCas9 NLS Null Mutant contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. |
ETHANOL, 70% CONCENTRATION |
IB15727 |
IBI Scientific |
10L |
EUR 210.13 |
Description: BOX W/SPIGOT (HAZ) |